Todd Michael Wider
Independent DirectorDr. Todd Michael Wider, M.D., served as an Independent Director at Genenta Science S.p.A. from May 02, 2024 until 2025. He has been an Independent Director at ASP Isotopes Inc. since October 2021. He served as an Independent Director at Abeona Therapeutics Inc since May 7, 2015 until May 2023. He served as Independent Director at ARYA Sciences Acquisition Corp III since August 2020 to June 2021. He is also on the boards of Varian Biopharma, Xanadu Bio and Lyfebulb. He serves as Independent Director of ARYA Sciences Acquisition Corp V and ARYA Sciences Acquisition Corp IV since July 2021. He serves as Executive Chairman at Emendo Biotherapeutics, Inc. since June 2018 and was it's Chief Marketing Officer. Dr. Wider is Chief medical Officer at Emendo Bio, Inc. He also served on the board of ARYA III. Dr. Wider served as an Independent Director at ARYA Sciences Acquisition Corp II since July 21, 2020 until November 2020. Dr. Wider served as a Director of ARYA Acquisition Sciences Corporation I from October 2018 to March 2020. Dr. Wider is a surgeon and has served as consultant to numerous entities in the biotechnology space. Dr. Wider is also a Principal in Wider Film Projects, a documentary film company focusing on producing films with sociopolitical resonance. Dr. Wider has a strong medical background and significant experience in small and mid-cap biotechnology companies. Dr. Wider has extensive experience in the biotechnology investment community and has been a consultant to leading healthcare institutional Investors. His experience includes public and private financings, corporate development and licensing transactions in the biotechnology and medical device industries. Dr. Wider is an active, honorary Member of the medical staff of Mount Sinai Hospital in New York and is a plastic and reconstructive surgeon who focused on cancer surgery. He did his residency in general surgery and plastic and reconstructive surgery at Columbia Presbyterian Medical Center and postdoctoral fellowships in complex reconstructive surgery at Memorial Sloan Kettering Cancer Center, where he was Chief Microsurgery Fellow and in craniofacial surgery at the University of Miami. Dr. Wider also served as a Director of ARYA Sciences Acquisition Corporation from October 2018 to June 2020. Dr. Wider serves as an Independent Director at ARYA Sciences Acquisition Corp IV since January 2021. Dr. Wider received an MD from Columbia College of Physicians and Surgeons, where he was Rudin Fellow and a BA in history of art and architecture with high honors and Phi Beta Kappa from Princeton University.
公司职务
- 公司名称ASP Isotopes Inc.股票代码ASPI职务Independent Director共事同僚
- PEPaul Elliot MannExecutive Chairman & CEO
- HKHeather KiesslingChief Financial Officer
- RARobert AinscowChief Operating Officer
- NMNicholas Michael MitchellCo-Chief Operating Officer
- HSHendrik StrydomChief Technology Officer
- DMDuncan MooreIndependent Director
- RRRobert RyanIndependent Director
- MGMichael GorleyIndependent Director
